Authors:
Abadie, V
Andre, A
Zaouche, A
Thouvenin, B
Baujat, G
Schmitz, J
Citation: V. Abadie et al., Early feeding resistance: A possible consequence of neonatal oro-oesophageal dyskinesia, ACT PAEDIAT, 90(7), 2001, pp. 738-745
Authors:
Amiel, J
Attie-Bitach, T
Marianowski, R
Cormier-Daire, V
Abadie, V
Bonnet, D
Gonzales, M
Chemouny, S
Brunelle, F
Munnich, A
Manach, Y
Lyonnet, S
Citation: J. Amiel et al., Temporal bone anomaly proposed as a major criteria for diagnosis of CHARGEsyndrome, AM J MED G, 99(2), 2001, pp. 124-127
Authors:
Abadie, V
Wiener-Vacher, S
Morisseau-Durand, MP
Poree, C
Amiel, J
Amanou, L
Peigne, C
Lyonnet, S
Manac'h, Y
Citation: V. Abadie et al., Vestibular anomalies in CHARGE syndrome: investigations on and consequences for postural development, EUR J PED, 159(8), 2000, pp. 569-574
Authors:
Fortin, G
del Toro, ED
Abadie, V
Guimaraes, L
Foutz, AS
Denavit-Saubie, M
Rouyer, F
Champagnat, J
Citation: G. Fortin et al., Genetic and developmental models for the neural control of breathing in vertebrates, RESP PHYSL, 122(2-3), 2000, pp. 247-257
Authors:
Saliba, Z
Bah, G
Martin, D
Abadie, V
Azar, Z
Fraisse, A
Sidi, D
Kachaner, J
Bonnet, D
Citation: Z. Saliba et al., Pseudo inherited left heart obstructive defects revealing a maternal phenylketonuria., ARCH MAL C, 93(5), 2000, pp. 649-652
Authors:
Benit, P
Rey, F
Blandin-Savoja, F
Munnich, A
Abadie, V
Rey, J
Citation: P. Benit et al., The mutant genotype is the main determinant of the metabolic phenotype in phenylalanine hydroxylase deficiency, MOL GEN MET, 68(1), 1999, pp. 43-47
Authors:
Dannoura, AH
Berriot-Varoqueaux, N
Amati, P
Abadie, V
Verthier, N
Schmitz, J
Wetterau, JR
Samson-Bouma, ME
Aggerbeck, LP
Citation: Ah. Dannoura et al., Anderson's disease - Exclusion of apolipoprotein and intracellular lipid transport genes, ART THROM V, 19(10), 1999, pp. 2494-2508
Authors:
Sermet-Gaudelus, I
Stambouli, F
Abadie, V
Goutieres, F
Lenoir, G
Gendrel, D
Gaillard, JL
Citation: I. Sermet-gaudelus et al., Rapid improvement of intracranial tuberculomas after addition of ofloxacinto first-line antituberculosis treatment, EUR J CL M, 18(10), 1999, pp. 726-728